Agoracom: Small Cap Investment - Mannkind - Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog i

Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Reply New Message

Back To Forum List View

Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog i

brentie98

Mar 16, 2013 03:09PM

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog i

BobW

Mar 17, 2013 04:47PM

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog i

brentie98

Mar 17, 2013 05:07PM

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog i

liahall

Mar 17, 2013 05:07PM

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog i

brentie98

Mar 17, 2013 05:27PM

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog i

greasecan

Mar 17, 2013 05:27PM

BobW

Rank: Vice President [?]

Points: 1080 [?]

Votes: 11 Score: 4.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog i

in response to

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog i

liahall

posted on Mar 17, 2013 05:54PM

Thanks again Lia; I do remember that post now. Is it possible that they have found a way to inject insulin monomers, or does the fact that they are calling it a formulation of insulin aspart imply that it is still insulin hexamers?

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog i

seaside

Mar 17, 2013 06:01PM

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog i

Dreggy

Mar 17, 2013 06:27PM

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog i

liahall

Mar 17, 2013 07:03PM

Re: Novo Nordisk to Begin Phase 3 Studies of Ultra-Rapid-Acting Version of Novolog i

BobW

Mar 17, 2013 07:35PM